458 related articles for article (PubMed ID: 32413499)
1. Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers.
Ozawa PMM; Jucoski TS; Vieira E; Carvalho TM; Malheiros D; Ribeiro EMSF
Transl Res; 2020 Sep; 223():40-60. PubMed ID: 32413499
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.
Yoshioka Y; Katsuda T; Ochiya T
Jpn J Clin Oncol; 2018 Oct; 48(10):869-876. PubMed ID: 30169666
[TBL] [Abstract][Full Text] [Related]
4. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
Barone I; Gelsomino L; Accattatis FM; Giordano F; Gyorffy B; Panza S; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Bonofiglio D; Andò S; Giordano C; Catalano S
J Transl Med; 2023 Mar; 21(1):232. PubMed ID: 37004031
[TBL] [Abstract][Full Text] [Related]
5. Polymer-Based Precipitation of Extracellular Vesicular miRNAs from Serum Improve Gastric Cancer miRNA Biomarker Performance.
Chung KY; Quek JM; Neo SH; Too HP
J Mol Diagn; 2020 May; 22(5):610-618. PubMed ID: 32151712
[TBL] [Abstract][Full Text] [Related]
6. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles.
Koi Y; Tsutani Y; Nishiyama Y; Ueda D; Ibuki Y; Sasada S; Akita T; Masumoto N; Kadoya T; Yamamoto Y; Takahashi RU; Tanaka J; Okada M; Tahara H
Cancer Sci; 2020 Jun; 111(6):2104-2115. PubMed ID: 32215990
[TBL] [Abstract][Full Text] [Related]
7. Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis.
Lee Y; Ni J; Beretov J; Wasinger VC; Graham P; Li Y
Mol Cancer; 2023 Feb; 22(1):33. PubMed ID: 36797736
[TBL] [Abstract][Full Text] [Related]
8. Multi-miRNA panel of tumor-derived extracellular vesicles as promising diagnostic biomarkers of early-stage breast cancer.
Kim MW; Park S; Lee H; Gwak H; Hyun KA; Kim JY; Jung HI; Il Kim S
Cancer Sci; 2021 Dec; 112(12):5078-5087. PubMed ID: 34626053
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas.
Drees EEE; Pegtel DM
Trends Cancer; 2020 Nov; 6(11):910-923. PubMed ID: 32660885
[TBL] [Abstract][Full Text] [Related]
10. The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast Cancer.
Schwich E; Rebmann V
Front Immunol; 2018; 9():584. PubMed ID: 29632535
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicle-based liquid biopsy holds great promise for the management of ovarian cancer.
Zheng X; Li X; Wang X
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188395. PubMed ID: 32698041
[TBL] [Abstract][Full Text] [Related]
12. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
Minciacchi VR; Zijlstra A; Rubin MA; Di Vizio D
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):251-258. PubMed ID: 28374743
[TBL] [Abstract][Full Text] [Related]
14. Impact of Extracellular Vesicle Isolation Methods on Downstream Mirna Analysis in Semen: A Comparative Study.
Mercadal M; Herrero C; López-Rodrigo O; Castells M; de la Fuente A; Vigués F; Bassas L; Larriba S
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824915
[TBL] [Abstract][Full Text] [Related]
15. Protein biomarkers in breast cancer-derived extracellular vesicles for use in liquid biopsies.
Li D; Lai W; Fan D; Fang Q
Am J Physiol Cell Physiol; 2021 Nov; 321(5):C779-C797. PubMed ID: 34495763
[TBL] [Abstract][Full Text] [Related]
16. Plasma extracellular vesicle‑packaged microRNAs as candidate diagnostic biomarkers for early‑stage breast cancer.
Yan C; Hu J; Yang Y; Hu H; Zhou D; Ma M; Xu N
Mol Med Rep; 2019 Nov; 20(5):3991-4002. PubMed ID: 31545424
[TBL] [Abstract][Full Text] [Related]
17. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
[No Abstract] [Full Text] [Related]
18. Extracellular Vesicles as Biomarkers and Therapeutic Targets in Breast Cancer.
Sadovska L; Eglītis J; Linē A
Anticancer Res; 2015 Dec; 35(12):6379-90. PubMed ID: 26637847
[TBL] [Abstract][Full Text] [Related]
19. Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer.
Moloney BM; Gilligan KE; Joyce DP; O'Neill CP; O'Brien KP; Khan S; Glynn CL; Waldron RM; Maguire CM; Holian E; Naughton E; Elhadi M; Grealish AB; Malone C; McDermott E; Dockery P; Ritter T; Prina-Mello A; Kerin MJ; Dwyer RM
Cells; 2020 Jan; 9(1):. PubMed ID: 31936142
[TBL] [Abstract][Full Text] [Related]
20. Circulating MicroRNAs in Extracellular Vesicles as Potential Biomarkers of Alcohol-Induced Neuroinflammation in Adolescence: Gender Differences.
Ibáñez F; Ureña-Peralta JR; Costa-Alba P; Torres JL; Laso FJ; Marcos M; Guerri C; Pascual M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
